. 2024 Jun 30;36(3):298–305. doi: 10.21147/j.issn.1000-9604.2024.03.06

Table 2. Stratification analysis for association of XPC and XPD genotypes with hepatoblastoma susceptibility in Eastern Chinese children.

Variables	XPC rs2229090 (case/control) (n)		AOR (95% CI)^a	P^a	XPD rs3810366 (case/control) (n)		AOR (95% CI)^a	P^a	XPD rs238406 (case/control) (n)		AOR (95% CI)^a	P^a
Variables	GG	GC/CC	AOR (95% CI)^a	P^a	GG	GC/CC	AOR (95% CI)^a	P^a	GG	GT/TT	AOR (95% CI)^a	P^a
AOR, adjusted odds ratio; 95% CI, 95% confidence interval. ^a, adjusted for age and sex, omitting the corresponding stratify factor.
Age (month)
<17	39/152	66/217	1.19 (0.76−1.86)	0.455	21/113	84/256	1.77 (1.04−2.99)	0.034	38/106	67/263	0.71 (0.45−1.12)	0.143
≥17	25/176	63/228	1.95 (1.18−3.22)	0.010	16/101	72/302	1.49 (0.83−2.69)	0.180	34/118	54/285	0.66 (0.41−1.06)	0.085
Sex
Female	22/136	56/187	1.84 (1.07−3.17)	0.027	19/88	59/234	1.19 (0.67−2.10)	0.562	29/96	49/226	0.71 (0.42−1.20)	0.199
Male	42/192	73/258	1.30 (0.85−1.99)	0.222	18/126	97/324	2.17 (1.26−3.75)	0.005	43/128	72/322	0.67 (0.43−1.02)	0.063
Clinical stages
I+II	34/328	76/445	1.65 (1.07−2.54)	0.022	20/214	90/558	1.78 (1.07−2.98)	0.027	44/224	66/548	0.61 (0.40−0.92)	0.020
III+IV	18/328	43/445	1.76 (1.00−3.10)	0.052	13/214	48/558	1.41 (0.75−2.66)	0.289	20/224	41/548	0.84 (0.48−1.47)	0.538